32 min
Episode 36: IRS Warnings, FDA's Approval of Wegovy, and More Cammayo's Compliance Talk
-
- Management
On this episode of Ask Michelle, Michelle is joined by special guest KC Rippstein, Compliance Practice Lead at IMA. They provided updates on the San Francisco HCSO Annual Reporting Form, the FDA's approval of Wegovy for cardiovascular disease prevention, and IRS Warnings regarding Employee Retention Credits (ERC) and FICA wellness savings programs.
Michelle and KC answered questions regarding the pretax indemnity plan in regard to critical illness and whether C-Corp Shareholders can participate in an HRA/FSA.
Curious about a compliance issue? Submit your questions to AskMichelle@imacorp.com and Michelle will answer them on the next episode.
On this episode of Ask Michelle, Michelle is joined by special guest KC Rippstein, Compliance Practice Lead at IMA. They provided updates on the San Francisco HCSO Annual Reporting Form, the FDA's approval of Wegovy for cardiovascular disease prevention, and IRS Warnings regarding Employee Retention Credits (ERC) and FICA wellness savings programs.
Michelle and KC answered questions regarding the pretax indemnity plan in regard to critical illness and whether C-Corp Shareholders can participate in an HRA/FSA.
Curious about a compliance issue? Submit your questions to AskMichelle@imacorp.com and Michelle will answer them on the next episode.
32 min